Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

VIMRx acquires rights to compounds based on RILON technology

April 26, 1996

SKB receives rights to OraSolve dosage technology from CIMA

April 26, 1996

Oxford Molecular, Yamanouchi to codevelop ion channel modulators

April 26, 1996

RMP-7 advances to phase I/II in Europe

April 26, 1996

SIBIA, Ciba-Geigy extend drug discovery agreement

April 26, 1996

Roche licenses access to LIFESEQ database

April 26, 1996

SIBIA, Salk Institute expand agreement for NAChRs

April 26, 1996

GS-2888, permeation enhancer reported by Gilead, Glaxo Wellcome

April 19, 1996

Signal, Tanabe Seiyaku to collaborate on drug discovery

April 19, 1996

Pharmacopeia will collaborate with Daiichi for drug discovery

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...